Ann: ZLD secures US$8.6 million funding for HOPE 1 US FDA trials, page-22

A bit further to my last post above as well as @gregwallis saying "It is not hard to believe that 9 million doses have been sold, but have they been giving them away? Where do they show up as income? Surely they would make $1 per dose? If not, why not." I did a quick search to try to find the cost of HOPE1 - this is a result courtesy of our very own 7News about a year ago.
Due acknowledgement to them :-

https://7news.com.au/news/public-health/can-medicinal-cannabis-be-used-to-help-children-with-autism-in-australia-c-5917389

It indicates that it costs a particular mum around $500AUD per 30ml bottle of HOPE1 - per month, no rebate at the time.
So that would be a direct sale as prescribed by the looks of it.

ZLD only mention Pennsylvania for confirmed sales/dispensing of over 9 million 'doses' by their licensee.
So one question there is ..how much quantity is in a 'dose' and what's the cost of it ?

They were showing steady revenue of, say, $380k average per Quarter for the last FY - but a massive drop for the past 2 quarters all of a sudden..down to $75k followed by $45k....

Now suddenly there's a huge investment coming in for HOPE1 trials.

Dyor but it makes me wonder if something happened to stop/inhibit licencing and sales of Hope1&2.

Finally from me, this funding is for the trials, which appear to have a 3-yr expectancy.

They still need cash for normal operating concerns, therefore there's still a chance of a CR imo.